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ABSTRACT Nystatin interaction with liposomes mimicking fungal and mammalian membranes (ergosterol- and cholesterol-
containing 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) large unilamellar vesicles, respectively) was studied by
ﬂuorescence spectroscopy. The activity of this antibiotic was also measured using a pyranine ﬂuorescence detected K1/H1
exchange assay. Nystatin mean ﬂuorescence lifetime varied with the antibiotic concentration and ergosterol content (0–30
mol%) of the lipid vesicles. It sharply increased from 5 to 37 ns upon reaching 100 molecules per liposome, reporting nystatin
oligomerization in the membrane. Concomitantly, spectral alterations typical of excitonic coupling were detected and there was
a pronounced increase in the initial rate of pore formation by nystatin. These ﬁndings suggest that nystatin exerts its antibiotic
activity via a two-stage mechanism: at low antibiotic concentrations, surface-adsorbed monomeric antibiotic molecules perturb
the lipid packing, changing the permeability properties of the ergosterol-rich liposomes. Upon reaching a critical threshold,
nystatin mode of action switches to the classical model of transmembrane aqueous channel formation. In the presence of
cholesterol-containing POPC liposomes, neither nystatin spectroscopic properties, nor the kinetics of K1 efﬂux varied with the
antibiotic concentration suggesting that in this case the ﬁrst stage of antibiotic mode of action always prevails or the assemblies
formed by nystatin and cholesterol are very loose.
INTRODUCTION
Polyene macrolide antibiotics isolated from Streptomyces
Gram-positive bacteria have been identiﬁed as antifungal
agents presenting a very low antibacterial activity. Ampho-
tericin B (AmB) and nystatin, which are two representative
members of this class of compounds, exert their antibiotic
activity via permeabilization of the target plasma membrane
of the antibiotic-sensitive organisms leading to a leakage of
ions and small molecules, ultimately causing cell destruction
(Bolard, 1986). It has been shown that these molecules are
able to self-aggregate and form large conductance pores with
size-discriminating properties in model membrane systems
(Kleinberg and Finkelstein, 1984) as well as single ion
channels in planar lipid bilayers (BLM) (Ermishkin et al.,
1977; Kleinberg and Finkelstein, 1984; Brutyan andMcPhie,
1996). However, the molecular details of the mechanism of
antibiotic interaction with, insertion into, and ﬁnal organi-
zation within the membranes are still not clear.
One of the most intriguing questions related to this class of
compounds is the elucidation of the role of sterols in their
mode of action. The most widespread model considers the
formation of stoichiometric antibiotic-sterol complexes
organized as barrel-like membrane-spanning channels in
the lipid bilayers (de Kruijff and Demel, 1974). The selective
toxicity of the polyene antibiotics between pathogenic
eukaryotic organisms and animal cells would then be related
to their stronger afﬁnity toward ergosterol, present in the
fungal membranes, relatively to cholesterol, found in the
membranes of mammalian cells (Bolard, 1986). Alterna-
tively, the sterols may have only an ordering function
packing the polyene molecules together, not directly
participating in channel formation (Kleinberg and Finkel-
stein, 1984). Bolard et al. (1991) considered instead that the
key factor governing their mode of action was the aggrega-
tion state of the antibiotic in solution; soluble monomeric
AmB could be very active toward ergosterol-containing
membranes, but a soluble self-associated oligomer was
required for the permeabilization of cholesterol-containing
membranes.
Direct spectroscopic evidence supporting the formation of
antibiotic-sterol complexes would be of fundamental impor-
tance to validate the ﬁrst hypothesis. However, Dufourc et al.
(1984) failed to detect an AmB-induced cholesterol immo-
bilization by deuterium nuclear magnetic resonance (NMR)
as the one described later for a smaller polyene antibiotic,
ﬁlipin (Dufourc and Smith, 1985). On the other hand,
conﬂicting data have accumulated suggesting that these anti-
biotics may have amultiplicity of modes of action that depend
on the membrane properties (Hartsel et al., 1993). Several
studies have even questioned the obligatory presence of
a sterol in a membrane in order for the polyene antibiotics to
be able to induce a leakage of monovalent ions, particularly
K1 ions, from the membranes. However, a comparison
between the conditions employed in most of these experi-
ments revealed that the main factor responsible for this effect
was the use of strained phospholipid bilayers. Both the
high-curvature radius of small unilamellar vesicles (SUV)
(Milhaud et al., 1989; Whyte et al., 1989; Hartsel et al., 1991)
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and the increased volume of the osmotically stressed large
unilamellar vesicles (LUV) (Weakliem et al., 1995; Ruck-
wardt et al., 1998) caused a decrease in the packing density of
the phospholipids present in the outer monolayer of the
vesicles, thereby promoting the interaction of the antibiotic
with the liposomes and its subsequent self-aggregation in the
lipid bilayer.
From the above, it can be concluded that studies designed to
achieve a comprehensive understanding about the nature of
antibiotic/sterol interactions are needed. As a ﬁrst contribu-
tion toward this goal, we have compared the properties of the
active species formed by the polyene antibiotic nystatin in
ergosterol- and cholesterol-containing membranes. The
structural information gained from ﬂuorescence spectro-
scopic studies (using both steady-state and time-resolved
measurements) was correlated with functional data obtained
from membrane permeabilizing activity assays. Our aims
were: i), to identify themain steps of nystatinmode of action at
the membrane level, ii), to detect the antibiotic species
produced at each stage, and iii), to investigate the role played
by sterols (ergosterol and cholesterol) in their formation.
Based on our results, a two-stage mechanism is presented for
nystatin activity in ergosterol-containing target membranes.
A nonspeciﬁc membrane permeabilization mechanism is
proposed for low occupancy numbers of the ergosterol-
containing lipid vesicles that switches to the nystatin classical
model of channel formation when a threshold antibiotic
surface concentration of ;100 nystatin molecules per lipid
vesicle is reached. Although the exact architecture of the
channels formed by nystatin remains to be clariﬁed, this study
strongly supports the view that at least ergosterol is directly
involved in their formation. Regarding cholesterol-containing
POPC liposomes, our data suggest that either stage two is
never reached or the structure of the aggregates formed by the
antibiotic in these experimental conditions is less compact
than the ones formed in the presence of ergosterol, not being
able to induce an increase in nystatin mean ﬂuorescence
lifetime. Altogether this study provides further evidence that
nystatin binding and assembly in lipid membranes is
a complex process that depends critically on the membrane
composition.
MATERIALS AND METHODS
Reagents
Nystatin was obtained from Sigma Chemical (St. Louis, MO) and was used
without further puriﬁcation. The antibiotic and its 1-mM stock solution
prepared in methanol (spectroscopic grade) were stored in the dark at
20C. The phospholipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC) and 1-palmitoyl-2-stearoyl(11-12)dibromo-sn-glycero-3-phos-
phocholine (BrPC) were purchased from Avanti Polar Lipids (Alabaster,
AL), either as a solid or in a chloroform solution (20 mg/mL). Ergosterol
(.98%) and cholesterol (.99%) were purchased from Fluka (Buchs,
Switzerland) and Merck (Whitehouse Station, NJ), respectively. The stock
solutions of phospholipids and sterols were prepared in chloroform and also
kept at 20C. The ionophores nigericin (sodium salt), valinomycin, and
FCCP (carbonyl cyanide p-(triﬂuoromethoxy)phenylhydrazone) were
purchased from Sigma Chemical. The stock solutions of nigericin (0.5 mM
in ethanol), valinomycin, and FCCP (1.8 and 4 mM in anhydrous dimethyl
sulphoxide, respectively) were stored at 4C. HPTS (8-hydroxypyrene-
1,3,6-trisulfonic acid, trisodium salt) or pyranine was purchased from
Molecular Probes (Eugene, OR). All other chemicals were of analytical or
reagent grade.
LUV preparation
LUV with a mean diameter of 100 nm were prepared using the extrusion
technique according to Mayer et al. (1986). Aqueous phospholipid
suspensions were prepared by premixing ergosterol or cholesterol with
POPC in the desired molar ratios as solutions in chloroform and evaporating
the solvent in a stream of nitrogen, followed by placing the lipid residue in
a vacuum pump overnight. The sterol mol fractions used were 0, 7.5, 10, 15,
and 30 mol%. The residual lipid ﬁlm, warmed to 50C in a water bath, was
hydrated with HEPES buffer (20 mM HEPES-NaOH (pH 7.4) with 150 mM
NaCl and 1 mM EDTA) and repeatedly vortexed until all lipid was removed
from the walls of the round-bottom ﬂask. Then a freeze-thaw cycle was
repeated eight times using liquid nitrogen and a water bath warmed to 50C.
Subsequently, the lipid suspension was extruded four and 10 times through
polycarbonate membranes of 400- and 100-nm pore size (Nuclepore,
Pleasanton, CA), respectively. The resulting stock solution was stored at
4C. The ﬁnal phospholipid concentration was determined by phosphate
analysis (McClare, 1971).
Nystatin partitioning experiments
Due to the presence of a ﬂuorescent impurity in ergosterol, both a separation
and a spectroscopic method were used to determine the mol fraction partition
coefﬁcients of nystatin. The separation method was based upon the
centrifugation of the liposomes prepared with brominated phospholipids
(White et al., 1998). Brieﬂy, LUV of BrPC with variable sterol mol fractions
(ﬁnal lipid concentration of 7 mM), were prepared by the extrusion method.
Diluted BrPC LUV (1–4 mM) and nystatin (;5 mM ﬁnal antibiotic
concentration) were mixed, and incubated for at least 1 h at room
temperature. The samples were sedimented (Sigma 2K15 centrifuge) at
25C progressively by spinning at 4500, 9000, and 16,000 3 g for 30 min
each. The supernatant was removed and centrifuged again at 18,0003 g for
1 h. Under these conditions, the fraction of lipid in the supernatant was
,4%. The total and free nystatin concentrations were assayed by absorption
spectrophotometry. The mol-fraction partition coefﬁcient, Kp, of the
antibiotic was calculated as White et al. (1998):
Kp ¼ ½Nl
½Lav
½Nw
½W; (1)
where [N]i (i ¼ l and i ¼ w) is the nystatin concentration in the lipid and
water phases, respectively. The amount of antibiotic bound to the lipid was
determined by subtracting the free antibiotic concentration from the total
antibiotic concentration. [L] and [W] are the molar concentrations of lipid
and water, respectively. It was always assumed that only 50% of the
overall lipid used, [L]av, was available for the initial partitioning of the
antibiotic.
The spectroscopic method used relies upon measuring the increase in
the ﬂuorescence intensity of the antibiotic upon its partitioning into the
lipid bilayers (Coutinho and Prieto, 2003). The samples were prepared as
described in the ‘‘LUV preparation’’ section and the ﬂuorescence signal
of 7.5 mM nystatin was monitored as a function of the lipid concentration
used. Background intensities in nystatin-free samples due to the lipid
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vesicles were always subtracted from each recording of ﬂuorescence
intensity.
The partitioning experiments were analyzed according to Eq. 2:
DI ¼ DImaxKp½Lav½W1Kp½Lav
: (2)
In this equation, DI¼ I  I0 stands for the difference between the steady-
state ﬂuorescence intensity of the antibiotic measured in the presence (I) and
in the absence of lipid vesicles (Io) and DImax ¼ IN  I0 is the maximum
value of this difference, because IN is the limiting value of I measured upon
increasing the available lipid concentration, [L]av, of the solution.
The partition coefﬁcient of the antibiotic can be used to compute the mol
fraction of membrane-bound monomeric antibiotic molecules, xl:
xl ¼ Kp½Lav½W1Kp½Lav
: (3)
The mean number of antibiotic molecules associated with a lipid vesicle,
ÆAæ, is calculated from Eq. 4:
ÆAæ ¼ mxl½Nt½Lt
: (4)
Here, m is the average number of lipid molecules per lipid vesicle (Table
1) and [N]t and [L]t are the overall antibiotic and lipid concentrations present
in a sample, respectively.
Nystatin activity measurements
LUV prepared with a variable lipid composition containing the pH-sensitive
ﬂuorophore pyranine were used to probe nystatin’s ability in inducing an
H1/K1 exchange across the membrane bilayer. Dried POPC ﬁlms with 0 or
10 mol% cholesterol or ergosterol were hydrated with a 0.5 mM pyranine
solution in K buffer at pH 7.4 (20 mM HEPES-KOH (pH 7.4) with 100 mM
K2SO4), subjected to eight freeze-thaw cycles, and subsequently extruded to
prepare pyranine-loaded LUV. Untrapped pyranine was removed by gel
ﬁltration on a Sephadex G25 column that was equilibrated with K buffer at
pH 7.4. Calibration of the pH-dependence of the ﬂuorescence signal of the
entrapped ﬂuorophore was performed by diluting 0.6 mL of pyranine loaded
vesicles prepared with a variable lipid composition into 1.4 mL of K buffer
directly in a ﬂuorescence cuvette. The liposomes were then permeabilized to
protons through the addition of 1.25 mM nigericin to the medium. The
presence of this ionophore certiﬁed that the pH inside and outside the
vesicles (pHin and pHout, respectively) were balanced throughout the entire
experiment. After adding small aliquots of 2.5 M KOH or 1 M H2SO4 to the
liposome suspension, the pyranine ﬂuorescence intensity, If, and the pH of
the solution (measured using a pH microelectrode) were simultaneously
measured while the solution was magnetically stirred. The pKa of the
entrapped pyranine was evaluated by ﬁtting Eq. 5 to the experimental data of
If versus pH. The maximal and minimal ﬂuorescence intensities of the dye,
Imax and Imin, respectively, were also considered as variable parameters in
this ﬁtting procedure.
pH ¼ pKa1 logðIf  IminÞðImax  IfÞ: (5)
Under the conditions used, the ﬂuorescence intensity of the entrapped
pyranine was found to be linear with respect to pH for 7.0 , pH , 7.8
( pKa ¼ 7.3–7.4).
The effect of nystatin on the potassium permeability of the lipid vesicles
was monitored indirectly through measuring the variation in the ﬂuorescence
intensity of pyranine-loaded vesicles upon adding aliquots of the antibiotic
to the lipid suspension. Brieﬂy, 0.7 mL of pyranine-containing POPC LUV
(prepared with a variable mol fraction of sterol), were preincubated
overnight with the protonophore FCCP (at 6.7 mM ﬁnal concentration) to
allow for free equilibration of H1 ions. These liposomes were then subjected
to a transmembrane K1 gradient of 3.3:1 [K1]in/[K
1]out through direct
dilution of 0.6 mL of the previous lipid suspension into 1.4 mL of
osmotically balanced S buffer (20 mM HEPES-KOH (pH 7.4) with 0.23 M
sucrose) in a magnetically stirred ﬂuorescence quartz cuvette. After 120 s,
adequate aliquots of nystatin stock solution (5–25 mM ﬁnal concentration)
were added to the lipid suspension and the time course of the change in
pyranine ﬂuorescence intensity was followed at 510 nm (excitation at
460 nm). At the end of the experiment, the ﬂuorescence emission correspond-
ing to the total dissipation of the K1 gradient was measured after adding
the ionophore valinomycin (at 13.4 mMﬁnal concentration) to the lipid vesi-
cles. The ﬁnal lipid concentration in solution was ;1.2 mM. To prevent
submitting the vesicles to osmotic stress the osmolalities of the solution
inside (dye solution) and outside (S buffer) of the vesicles were checked by
means of a cryoscopic osmometer (Knauer, Berlin, Germany). It should be
further noted that the lipid bilayers are impermeable to sulfate ions, as well
as to pyranine even in the presence of the antibiotic nystatin (Bolard et al.,
1991).
Calibration of the response function of the system was carried out by
generating variable K1 gradients across the lipid bilayer. To this end, 0.6 mL
of pyranine-loaded vesicles preincubated with FCCP were directly diluted
into 1.4 mL of variable mixtures of K and S buffers in a ﬂuorescence cuvette.
The addition of valinomycin to each lipid suspension 5 min later was again
used to measure pyranine ﬂuorescence intensity corresponding to the total
dissipation of the K1 gradient. This signal was converted to pHeqin using
Eq. 5 and its dependence with the transmembrane potassium gradient used
in each assay was compared to the theoretical expectation (Kornberg et al.,
1972).
Absorption and ﬂuorescence measurements
Nystatin concentrations were determined photometrically using a Jasco
V-560 ultraviolet-visible spectrophotometer (Jasco, Tokyo, Japan) using e304¼
7.43 104 M1cm1 (Coutinho and Prieto, 1995). Steady-state ﬂuorescence
spectra were recorded on a SLM-Aminco 8100 Series 2 spectroﬂuorometer
(Rochester, NY), with double excitation and emission monochromators
using a 450 W Xe arc lamp. The conditions used in most nystatin
ﬂuorescence measurements were lexc ¼ 320 nm and lem ¼ 410 nm
(bandwidths of 4 nm). The ﬂuorescence intensity of the entrapped pyranine
was measured using lexc¼ 460 nm and lem¼ 510 nm (also with bandwidths
of 4 nm). All ﬂuorescence measurements were carried out under a right-angle
geometry using 0.5-cm pathlength quartz cuvettes, except for the activity
measurements where 1-cm pathlength quartz cuvettes were employed.
TABLE 1 Summary of the physical characteristics considered
for the lipid vesicles prepared with a variable sterol mol fraction
Sterol mol fraction
0 0.075 0.10 0.15 0.30
AS (nm
2) 0.63 0.59 0.58 0.56 0.48
m* 92,074 97,901 100,011 104,516 120,847
*The calculation of the average number of lipids in a single liposome, m,
was made assuming a homogeneous population of spherical lipid vesicles
with an external diameter of 100 nm and a bilayer thickness of 4.0 nm. The
condensing effect of cholesterol was taken into account by considering
a variable average cross-sectional molecular area, AS (Smaby et al., 1997).
It was further assumed that ergosterol had a similar effect to cholesterol on
the physical properties of the lipid bilayers.
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The steady-state anisotropies, Æræ, were determined according to
Lakowicz (1999):
Æræ ¼ IVV  GIVH
IVV1 2GIVH
; (6)
where Iij are the steady-state vertical and horizontal components of
the ﬂuorescence emission with excitation vertical (IVV and IVH) and hori-
zontal (IHV and IHH) to the emission axis. The correction for orientation-
dependent transmittance of the emission polarizer was determined using
horizontally polarized light to calculate the G factor (G ¼ IHV/IHH). Polari-
zation measurements were made using Glan-Thompson prism polarizers in
a single-channel detection system and an adequate blank was subtracted from
each intensity reading before calculating the anisotropy value.
The time-correlated single-photon timing method was used to obtain the
time-resolved ﬂuorescence data. Brieﬂy, the samples were excited at 320 nm
using a frequency-doubled cavity-dumped dye laser of 4-di-cyanomethy-
lene-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran, or DCM (Coherent
701-2, Santa Clara, CA), synchronously pumped by a mode-locked Ar1
laser (514.5 nm, Coherent Innova 200-10). The emission (at 410 nm)
was detected at the magic angle (54.7) relative to the vertically polar-
ized excitation beam using a Hamamatsu R-2809 MCP photomultiplier
(Hamamatsu, Japan) and the instrument response functions (80 ps FWHM)
for deconvolution were generated from scatter dispersion (silica colloidal).
The number of counts in peak channel was typically 20,000 and the number
of channels per curve used for analysis was 1000. Data analysis was carried
out using a nonlinear, least-squares iterative ﬁtting procedure based on the
Marquardt algorithm. The ﬂuorescence intensity decay curves obtained were
deconvoluted with the instrument response function and analyzed as a sum
of exponential terms:
IðtÞ ¼ +
n
i¼1
ai expðt=tiÞ; (7)
where I(t) is the ﬂuorescence intensity at time t and ai and ti are the
normalized amplitude and lifetime of component i. The goodness of ﬁt of the
multiexponential decay was judged by the reduced-x2 value (between 1.0
and 1.3), and inspection of the plots for random distribution of weighted
residuals and autocorrelation. The mean ﬂuorescence lifetime was calculated
as:
Ætæ ¼ +ait2i

+aiti: (8)
Activity data analysis
Analysis of nystatin functional assays was based on a simple theoretical
model of pore formation (assuming noninteracting uniform pores) de-
veloped by Schwarz and collaborators to explain the activity of membrane-
active compounds (Schwarz and Robert, 1990, 1992; Schwarz and
Arbuzova, 1995). Two different parameters were used for comparing
nystatin ability in generating electrogenic K1 currents. Considering that: i),
the drop of pHin over time reﬂects the acidiﬁcation of the inner vesicular
space that accompanies the rate-limiting nystatin-induced efﬂux of K1 ions
from the lipid vesicles, and ii), the ﬂuorescence intensity of the entrapped
pyranine varied linearly with respect to pH between pH values of 7.0 and
7.8, the percentage of transmembrane K1 gradient dissipation, P, was
calculated from:
P ¼ pH
0
in  pH300in
pH0in  pHvalin
 !
3100; (9)
where pHoin and pH
300
in are the pH inside the lipid vesicles at times t¼ 0 s and
t ¼ 300 s and pHvalin is the pH obtained after the addition of 13.4 mM
valinomycin.
Secondly, the apparent initial rate of pore formation by nystatin in the
liposomes, vo, was calculated from the initial slope of the function p#(t),
which is the apparent average number of pores per lipid vesicle that has been
formed from t ¼ 0 to t (Schwarz and Robert, 1990, 1992; Schwarz and
Arbuzova, 1995):
p#ðtÞ ¼ lnRðtÞ ¼ ln pHinðtÞ  pH
300
in
pH
0
in  pHvalin
 !
: (10)
R(t) is the retention function of the liposome population, as it describes
the time evolution of the fraction of potassium ions still retained in the
vesicles after the addition of nystatin to the liposome suspension, and which
is in excess relatively to its ﬁnal equilibrium value. pHin(t) is the time course
of the pH decrease of the inner vesicular space of the liposomes. When the
‘‘all-or-none’’ mode of potassium release applies, i.e., when the ﬁrst pore
formed by nystatin in each lipid vesicles is sufﬁciently long lived to allow
for the full dissipation of its transmembrane K1 gradient, R(t) can be used to
calculate directly the average number of pores per lipid vesicle in the course
of time t, p(t).
When there is a basal membrane permeability toward K1 ions, the data
were corrected for this effect assuming an additional dissipation process with
a rate constant ni, which is independent of nystatin action (Eq. 11)
pðtÞ ¼ p#ðtÞ1 vit: (11)
Here p*(t) is the noncorrected average number of pores per lipid vesicle
in the course of time t, a function that also includes the intrinsic K1/H1
exchange of the liposomes. The rate constant vi describing this process was
determined by a linear regression of the p*(t) versus t data obtained during
the period of time elapsed between the liposome and the antibiotic addition
to the ﬂuorescence cuvette in each activity assay.
RESULTS
Inﬂuence of lipid composition on
nystatin partitioning
Considering that the phase diagram of a phospholipid/sterol
mixture determines its properties at a given composition and
temperature, it was important to evaluate the effect that both
the membrane sterol type and mol fraction had on nystatin
partitioning behavior. Although a ﬂuorimetric method was
previously applied to measure nystatin binding to liposomes
(Coutinho and Prieto, 2003), it could not be used here with
POPC/ergosterol mixed bilayers. In fact, even though
ergosterol itself is a nonﬂuorescent compound at room
temperature (Nakashima et al., 1985), it always presents
a residual ﬂuorescent impurity, dehydroergosterol (DHE)
(Albro et al., 1997). We did not succeed in purifying
ergosterol by reversed-phase high-performance liquid chro-
matography as described (Albro et al., 1997), probably due
to its easy reoxidation. Therefore, its use in ﬂuorescence
partitioning studies was ruled out due to the need of using
highly concentrated lipid suspensions in these experiments
(typically up to 6–7 mM). In this case, an alternative tech-
nique (centrifugation method) was employed to determine
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nystatin partition coefﬁcients. Regarding cholesterol-containing
POPC LUV, both methods were applied to establish a
comparison between them.
The effect of membrane sterol type and content on the
partition coefﬁcient of nystatin is presented in Table 2.
Within the cholesterol concentration range examined (i.e., 5–
30 mol%) nystatin always presented a low mol-fraction par-
tition coefﬁcient toward the liposomes (Kp (1.760.3)3104
and Kp  (1.5 6 0.2) 3 104 using the spectroscopic and
separation methods, respectively), which was similar to
the value obtained for sterol-free lipid vesicles (Kp  (1.4 6
0.3) 3 104; Table 2). Upon substitution of cholesterol with
ergosterol, the partition behavior of the antibiotic did not
change, an average Kp  (1.5 6 0.2) 3 104 being now
obtained (also using 5–30 mol% ergosterol-containing
POPC LUV; Table 2). The inspection of Table 2 also shows
that the use of brominated phospholipids in the centrifuga-
tion method did not affect the partitioning behavior of the
antibiotic because the Kp values obtained for nystatin were
independent of the method used (separation or spectro-
scopic) in their determination.
Fluorescence spectra
The excitation and emission spectra of nystatin in interaction
with sterol-free and mixed bilayers of POPC/cholesterol
prepared with 7.5, 10, 15, and 30 mol% cholesterol were
essentially independent of the antibiotic concentration added
to the lipid vesicles, as it is exempliﬁed in Fig. 1, A and B,
respectively, for 2.5, 5.0, and 20 mM nystatin and 10 mol%
cholesterol-containing POPC LUV. The opposite behavior
was found for nystatin in interaction with ergosterol-
containing POPC LUV. Fig. 1 E shows that upon increasing
the overall nystatin concentration from 2.5 to 20 mM in the
presence of 10 mol% ergosterol-containing POPC LUV, the
antibiotic presented progressively amore structured and blue-
shifted emission spectra, with an isoemissive wavelength at
403 nm. The vibrational progression of its excitation spectra
was also strongly affected, the more concentrated antibiotic
samples presenting an increase in the intensities of the
transitions at higher (2)0 and 3)0) energies (Fig. 1 D).
Moreover, the wavelength maxima of the lower energy
transitions 0)0 and 1)0 gradually shifted from 322 and
307 nm to 325 and 309 nm, respectively (Fig. 1 D). These
spectral alterations were also noticed when studying nystatin
interaction with mixed bilayers of POPC/ergosterol prepared
with 7.5, 15, and 30 mol% ergosterol, and their detection was
always accompanied by a sharp increase in the ﬂuorescence
emission intensity of the antibiotic, as it is demonstrated in
Fig. 1 F for 10 mol% ergosterol-containing POPC LUV.
Concomitantly, nystatin absorption spectra were found to
remain essentially unaltered and the antibiotic samples
obeyed the Beer-Lambert law in both types of lipid mixtures
(data not shown). These data provide strong evidence for the
coexistence of different populations of antibioticmolecules in
the ergosterol-rich lipid vesicles with different spectral
properties and quantum yields.
It was also found that nystatin was unable to induce the
fusion/aggregation of the lipid vesicles because the light-
scattering intensity of each sample did not change upon
nystatin addition to the liposomes suspension, independently
of its lipid composition (data not shown).
Time-resolved ﬂuorescence measurements
The ﬂuorescence emission decay kinetics of nystatin was
measured in the presence of 0, 7.5, 10, 15, and 30 mol%
cholesterol-containing POPC LUV. According to x2 opti-
mization and deviation function criteria (random-weighted
residuals and autocorrelation plots), a four-exponential
model was always required to describe the ﬂuorescence
intensity decay curves of nystatin (data not shown). For each
cholesterol/POPC mixture studied, nystatin ﬂuorescence
decays were essentially independent of the antibiotic
concentration used within the range studied (2.5–25 mM)
(Fig. 2 A). On the other hand, the intensity-weighted mean
ﬂuorescence lifetime of nystatin slightly decreased from
;5.3 to 4.8 ns upon going from 0 to cholesterol mol
fractions higher than 10 mol%. This effect was mainly
caused by a small reduction of all nystatin lifetime
components for 15 and 30 mol% cholesterol-containing
POPC LUV (data not shown).
Upon changing the composition of the lipid vesicles from
cholesterol- to ergosterol-containing POPC LUV, the photo-
physical properties of nystatin changed dramatically. The
ﬂuorescence emission decay kinetics of the antibiotic now
TABLE 2 Mol-fraction partition coefﬁcients of nystatin, Kp,
for sterol-free and cholesterol- and ergosterol-containing
POPC LUV determined by a spectroscopic (ﬂuorescence)
and a separation method (centrifugation)
Kp (3 10
4)
Lipid system* xSterol Fluorescence Centrifugation
POPC 0 1.4 6 0.2 1.4 6 0.3
Cholesterol/POPC 0.05 2.2 6 0.2 1.5 6 0.2
0.075 1.6 6 0.3 –
0.10 1.7 6 0.2 1.7 6 0.5
0.15 1.7 6 0.4 –
0.20 1.9 6 0.7 1.4 6 0.4
0.30 1.3 6 0.5 1.3 6 0.6
Ergosterol/POPC 0.05 – 1.2 6 0.2
0.075 – –
0.10 – 1.5 6 0.4
0.15 – –
0.20 – 1.7 6 0.4
0.30 – 1.4 6 0.4
*It was considered that only the external leaﬂet of the lipid vesicles could
establish an interaction with the antibiotic. The antibiotic concentration
used in each assay was 7.5 mM, respectively.
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became sharply dependent upon both the sterol content of the
lipid vesicles (Fig. 2 B) and the overall antibiotic
concentration used (Fig. 2 A). As it is illustrated in Fig. 2 A
for 7.5 mol% ergosterol-containing POPC LUV, the
intensity-weighted mean ﬂuorescence lifetime of nystatin was
essentially invariant until its concentration reached 10 mM;
above this antibiotic concentration, Ætæ progressively in-
creased from ;5–8 ns to 25 ns at 25 mM nystatin. This
change was even more pronounced when higher ergosterol
mol fractions were used, as it is exempliﬁed in Fig. 2 A for 30
mol% ergosterol-containing POPC LUV. The conversion of
nystatin from a fast to a slow decaying ﬂuorescent species
was mainly caused by a sharp increase in nystatin longest
lifetime component from;6–8 ns to 42 ns (data not shown).
A similar variation of nystatin ﬂuorescence emission decay
kinetics has already been described for the antibiotic in
interaction with gel-phase DPPC vesicles (Coutinho and
Prieto, 1995). This behavior was demonstrated to be
essentially controlled by the mean number of membrane-
bound antibiotic molecules per lipid vesicle, ÆAæ, and was
therefore ascribed to nystatin oligomerization in the lipid
vesicles (Coutinho and Prieto, 2003). Here, Fig. 2 shows that
nystatin mean ﬂuorescence lifetime reaches a variable
plateau of 24.0, 29.7, and 35.9 ns for 15, 20, and 25 mM
nystatin, respectively, at;10 mol% ergosterol. According to
the previous model, these data imply that for ergosterol mol
fractions higher than 10 mol%, ergosterol is no longer the
limiting reagent for the formation of nystatin-ergosterol
mixed complexes. Therefore, for these antibiotic concen-
trations the replot of Ætæ as a function of ÆAæ can be used to
study this process in ergosterol-containing POPC LUV.
From inspection of Fig. 3 A, nystatin critical concentration
was found to increase from ÆAæ*  10 up to 100 upon
changing the lipid vesicles from gel-phase DPPC SUV and
LUV to ergosterol-containing POPC LUV, respectively.
Therefore, both the physical condition (gel/ﬂuid) and
chemical composition of the liposomes are important
features that modulate nystatin self-assembly in the system.
It should be noted that the ﬂuorescent impurity of
ergosterol (dehydroergosterol) caused a small decrease in
FIGURE 1 Corrected excitation (lem ¼
410 nm; A and D) and emission (lex ¼
320 nm; B and E ) ﬂuorescence spectra of
2.5 (thin solid line), 5.0 (dotted line), and
20 mM (thick solid line) nystatin in
interaction with 1.4 mM (A) 10 mol%
cholesterol- and (B) 10 mol% ergosterol-
containing POPC LUV. (Insets C and F)
Variation of the steady-state ﬂuorescence
intensities, corrected for the inner-ﬁlter
effect, with nystatin concentration for
each lipid system studied.
FIGURE 2 Effect of (A) nystatin concentration
and (B) membrane ergosterol content on the
intensity-weighted mean ﬂuorescence lifetime of
the antibiotic in interaction with 1.4 mM sterol-
containing POPC LUV at room temperature. (A)
The lipid compositions studied were: POPC (n),
7.5 mol% (h), and 30 mol% (n) cholesterol-
containing POPC LUV, and 7.5 mol% (s) and
30 mol% (d) ergosterol-containing POPC LUV,
respectively. (B) The antibiotic concentrations
studied were: 2.5 (;), 5.0 (n), 7.5 (:), 10 (h),
15 (n), 20 (s), and 25 mM (d) nystatin, re-
spectively. Lines were drawn just to guide the eye.
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the mean ﬂuorescence lifetime of the samples when both low
antibiotic concentrations (between 2.5 and 10 mM, Fig. 2 A)
and high ergosterol mol fractions ($10 mol%; Fig. 2 B) were
used. The mean ﬂuorescence lifetime of DHE itself was
essentially independent of the ergosterol content of the lipid
vesicles (Ætæ ¼ 1.9 6 0.6 ns). Considering that this impurity
did not interfere with the detection of the longest-lived
lifetime component of nystatin (t4  42 ns), which is the
characteristic signature of the slow-decaying antibiotic
species formed by nystatin in the lipid vesicles upon
increasing its overall concentration in solution, nonpuriﬁed
ergosterol could be used in all lifetime measurements.
Steady-state ﬂuorescence anisotropy
measurements
The steady-state ﬂuorescence anisotropy proﬁle of nystatin
as a function of the sterol content of the lipid bilayer is
plotted in Fig. 4. For POPC LUV, the anisotropy of 15, 20,
and 25 mM nystatin was Æræ ¼ 0.2716 0.007. The inclusion
of 10 or 15 mol% cholesterol did not inﬂuence appreciably
this parameter, which slightly decreased to Æræ ¼ 0.259 6
0.003 for 30 mol% cholesterol-containing POPC LUV. In
contrast, ergosterol had a more pronounced inﬂuence upon
nystatin rotational diffusion because its ﬂuorescence anisot-
ropy steadily increased from Æræ ¼ 0.271 6 0.007 to Æræ ¼
0.306 6 0.005 for POPC LUV containing .10 mol%
ergosterol (Fig. 4). This observation further supports the
conclusion that this antibiotic is forming mixed nystatin-
ergosterol complexes, which are rigid molecular aggregates,
as the increased ﬂuorescence anisotropy combined with
a longer ﬂuorescence lifetime is indicative of strongly
reduced mobility.
Nystatin activity assays
One of the primary effects known to be induced by the
polyene antibiotics on the cells is a loss of potassium ions
(Bolard, 1986). To test whether the changes found in nystatin
spectroscopic properties were accompanied by the formation
of functional antibiotic species, the effect of nystatin on the
permeability properties of the liposomes toward K1 ions was
examined using an activity assay developed by Hartsel and
co-workers (Whyte et al., 1989; Hartsel et al., 1991). The
change in ﬂuorescence emission at 510 nmof the pH-sensitive
ﬂuorescent dye pyranine entrapped inside LUVpreparedwith
a variable lipid composition was used to follow indirectly the
antibiotic-mediated efﬂux of K1 ions from the liposomes
(Fig. 5 A). The generation of a potassium gradient across the
phospholipid bilayer was required to measure the electrically
neutral transmembrane K1/H1 exchange and we chose to use
[K1]in¼ 3.3 [K1]out. Addition of nystatin to the suspension of
lipid vesicles lowered the ﬂuorescence intensity of the
entrapped dye reporting an acidiﬁcation of the inner vesicular
space (Fig. 5 A). In order for the inﬂux of protons (which
occurred simultaneously with the antibiotic-mediated efﬂux
of potassium ions) not to be rate limiting, the liposomes were
FIGURE 3 (A) Inﬂuence of lipid composition on the photophysical
behavior of nystatin in interaction with liposomes. The lipid vesicles used
were: gel-phase DPPC SUV (n) and LUV (:) (Coutinho and Prieto, 2003)
and POPC LUV containing 10 (d), 15 (n), and 30 mol% (h) of ergosterol.
The mean number of membrane-bound antibiotic molecules per liposome,
ÆAæ, was calculated according to Eq. 4. The solid lines are the best ﬁts of the
cooperative partition model of the antibiotic to the experimental data
obtained with gel-phase (z ¼ 6; K#ag ¼ 3:73 104 mmol5 (Coutinho and
Prieto, 2003) and ergosterol-rich lipid vesicles (z ¼ 8; K#ag ¼
1:73 104 mmol5; see the text for more details). The limiting values of
nystatin amplitude- and intensity-weighted mean ﬂuorescence lifetimes used
in the ﬁt were tMl ¼ 1.0 ns and ÆtæMl ¼ 3:3 ns for monomeric nystatin,
respectively, and tAgl ¼ 6:5 ns and ÆtæAgl ¼ 38 ns for the aggregates formed
by the antibiotic and ergosterol, respectively. (B, inset) Plot showing the
relationship between the lowest value of the root-mean-square deviations,
RMS, and the aggregation number of nystatin, z. K#ag was allowed to vary in
each ﬁtting whereas z was kept constant at different integer numbers.
FIGURE 4 Effect of membrane sterol content on the steady-state
ﬂuorescence anisotropy of nystatin in interaction with 1.4 mM (d)
ergosterol- and (s) cholesterol-containing POPC LUV at room temperature.
The error bars represent the standard deviation of the measurements obtained
with 15, 20, and 25 mM nystatin.
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preincubated with FCCP. The presence of this protonophore
was essential to preclude the buildup of a diffusion potential
created by the efﬂux of potassium ions that would otherwise
prevent the dissipation of the initial electrochemical gradient
present across the lipid vesicles. When the ionophore
valinomycin was added at the end of each experiment, the
pyranine signal instantaneously dropped to attain the
ﬂuorescence intensity corresponding to the equilibrium pH,
pHeqin ; due to the fully dissipation of the transmembrane K
1
gradient (Fig. 5A). The validation of this assaywas carried out
in control experiments by showing that the dependence of
pHeqin with the transmembrane potassiumgradient used in each
experiment followed the theoretical expectation within61%.
This is exempliﬁed in Fig. 5 C for POPC vesicles. These data
also evidence that the liposome populations used in these
experiments were essentially unilamellar because if a signif-
icant fraction of oligolamellar lipid vesicles was present, then
the value of pHeqin determined with the ionophore valinomycin
would become signiﬁcantly and reproducibly lower than the
expected theoretical value, as it was previously reported by
Hartsel et al. (1991).
The change of pyranine ﬂuorescence signal directly reﬂects
the number of pores formed by nystatin in each lipid vesicle
only if the antibiotic mode of action is of the ‘‘all-or-none’’
type. Otherwise, the normalized change of the pH inside the
lipid vesicles, R(t), can only be used to evaluate the apparent
number of activated pores per vesicle, p#(t), in the course of
time t as it is described in Materials and Methods (Fig. 5 B).
These curves can be analyzed through the calculation of two
different parameters, namely the percentage of transmem-
brane K1 gradient dissipated 300 s after the beginning of each
assay,P, and the apparent initial rate of pore formation, vo, by
nystatin in the liposomes. Fig. 6 shows a comparison between
the outcome of exposing sterol-free and sterol-containing
POPC vesicles submitted to a potassium gradient to variable
antibiotic concentrations. Both a more extensive (Fig. 6 A)
and faster (Fig. 6 B) decrease in the pyranine ﬂuorescence
intensity was detected in experiments carried out with 10
mol% ergosterol—compared to 10 mol% cholesterol-con-
taining POPC LUV. Furthermore, the apparent initial rate of
FIGURE 5 (A) Fluorescence-detected pH changes induced by nystatin in
a suspension of 10 mol% sterol-containing POPC LUV (cholesterol (solid
lines) and ergosterol (dotted lines)) with a 3.3:1 K1 gradient. After diluting
0.6 mL of the pyranine-loaded liposomes (preincubated with 6.7 mM FCCP)
into 1.4 mL of S buffer (L), 5 (thin lines), or 25mM (thick lines) nystatin (nys)
was added to the lipid suspension. Valinomycin at 13.4mM (val) was used as
a potassium-selective control. The ﬁnal lipid concentration was 1.4 mM. The
decrease in ﬂuorescence is due to K1/H1 exchange and demonstrates
electrogenic K1 currents caused by nystatin. (B) Illustration of the procedure
followed to correct the data for the basal K1/H1 exchange of the lipid
vesicles. The function p*(t) was calculated from the experimental data
obtained with 10 mM nystatin and 10 mol% ergosterol-containing POPC
LUV using Eqs. 10 and 11 (solid black curve a). The rate constant vi
describing the intrinsic K1/H1 exchange of the liposomeswas determined by
doing a linear regression of the baseline change of p*(t) in the absence of
nystatin (vi¼ 3.33 104 s1). The extrapolated straight line (dashed curve c)
was subtracted from the data (curve a) to rule out nonspeciﬁc defects and
leaks as a source of the observed change in ﬂuorescence. Curve b (solid gray
curve b¼ a c) describes the time evolution of the average number of pores
per lipid vesicle, p(t) or its apparent value, p#(t), depending on the mode of
potassium release by nystatin, i.e., ‘‘all-or-none’’ or graded release,
respectively (see text). (C) Exempliﬁcation of the dependence of the
acidiﬁcation of the inner vesicular space with the magnitude of the
transmembrane K1 gradient used. The calibration of the response function
of pyranine-loaded POPC LUV was carried out by generating variable K1
gradients across the lipid bilayers. The ﬂuorescence intensity of the entrapped
pyranine was measured 300 s after adding 13.4 mM valinomycin to the lipid
vesicles that were preincubatedwith FCCP (at 2mMﬁnal concentration). The
corresponding ﬁnal equilibrium value of the pH inside the lipid vesicles,
pHeqin ; was determined using Eq. 5. The solid line describes the theoretical
variation of pHeqin calculated according to Kornberg et al. (1972).
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pore formation by nystatin, vo, exhibited a strong dependence
with the antibiotic occupancy number of the lipid vesicles,
sharply increasing for ÆAæ $ 100 only for 10 mol%
ergosterol-containing POPC LUV (Fig. 6 B). This critical
concentrationwas coincident with the formation of long-lived
ﬂuorescent antibiotic species in these lipid vesicles (Fig. 6, B
andC). It is also shown in Fig. 6 that nystatin is able to induce
a slow but signiﬁcant increase in the permeability of sterol-
free POPC LUV to K1 ions within the antibiotic concentra-
tion range studied.
DISCUSSION
Nystatin interaction with sterol-containing
liposomes
The aim of this study was to investigate the sterol dependence
of the ﬂuorescence properties and membrane activity of the
polyene antibiotic nystatin. The ﬁrst step in the characteriza-
tion of nystatin interaction with sterol-containing POPC LUV
was the evaluation of its partition equilibrium because it was
anticipated that the well-known lipid-ordering effect of both
cholesterol (Vist and Davis, 1990) and ergosterol (Urbina
et al., 1995; Endress et al., 2002) could inﬂuence the antibiotic
distribution between the lipid bilayer and the bulk aqueous
phase. From the known partition coefﬁcients of nystatin, it is
possible to compute the mean number of membrane-bound
antibiotic molecules per lipid vesicle (Eqs. 3 and 4), a factor
that controls the surface activity and oligomerization state of
the antibiotic in gel phase lipid vesicles (Coutinho and Prieto,
2003). Therefore, the evaluation of Kp is of fundamental
importance because it allows for a reliable comparison to be
made between data obtained with liposomes prepared with
a variable sterol content (either cholesterol or ergosterol) and/
or total lipid concentration.
The partition coefﬁcients of nystatin were found to be
essentially independent of the sterol type and content of the
lipid vesicles used, always presenting a low value (Table 2).
According to the phase diagram of POPC/cholesterol
determined by de Almeida et al. (2003), at room temperature
(T ¼ 22C) there is a phase coexistence region of ‘d (or a)
and ‘o (or b) phases between ;11 and 45 mol% of
cholesterol. For 15, 20, and 30 mol% of cholesterol, the
fractions of ‘o phase present in the POPC/cholesterol binary
lipid mixtures are then expected to be ;12, 26, and 56%,
respectively. Because Kp is almost invariant within this
concentration range, it can be concluded that nystatin is not
extensively excluded from the liquid-ordered phase induced
by cholesterol in the lipid bilayers. Therefore, the decrease in
free volume available in the hydrophobic core of the bilayer
upon increasing the mol fraction of cholesterol (Straume and
Litman, 1987) does not seem to play a signiﬁcant role in
nystatin partitioning behavior. Considering the similar
ability of cholesterol and ergosterol in ordering phospholipid
bilayers (Urbina et al., 1995; Endress et al., 2002), the same
reasoning may be applied to this sterol.
Effect of membrane sterol type and content on
nystatin photophysical properties
This study conﬁrmed again the ability of nystatin ﬂuores-
cence emission decay kinetics to report its oligomerization
state in lipid membranes. Moreover, Fig. 2 clearly shows that
FIGURE 6 The active species formed by nystatin in the lipid vesicles
depend both on the antibiotic concentration used and on the lipid composition
of the lipid vesicles. Dependence of (A) the fraction of transmembrane K1
gradient dissipated 300 s after the beginning of each assay,P, (B) the apparent
initial rate of pore formation, vo, and (C) the intensity-weighted mean
ﬂuorescence lifetime of the antibiotic, Ætæ, with the mean number of
membrane-bound antibiotic molecules per liposome, ÆAæ. POPC LUV (n), 10
mol% ergosterol- (d), and 10 mol% cholesterol-containing POPC (s) were
used in these experiments. The dashed vertical line at ÆAæ ¼ 100 signals the
onset of the sharp increase simultaneously detected in the initial rate of pore
formation and in the mean ﬂuorescence lifetime of the antibiotic in the
presence of 10 mol% ergosterol-containing liposomes.
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the ergosterol content of the lipid vesicles also inﬂuenced the
photophysical behavior of the antibiotic. The establishment
of interactions between nystatin and ergosterol must
therefore drive their assembly and insertion into the
liposomes. Nystatin molecules are putatively more rigidiﬁed
in the sterol-antibiotic mixed complexes formed in the lipid
bilayer than in their monomeric form, their nonradiative deac-
tivation pathways decrease and, consequently, nystatin mean
ﬂuorescence lifetime increases from ;5 to 38 ns (Fig. 3 A).
For ergosterol mol fractions higher than 10 mol%, nystatin
mean ﬂuorescence lifetime reached an antibiotic-concentra-
tion dependent plateau showing that this sterol is no longer
the limiting reagent for heteromeric complex formation with
nystatin (Fig. 2 B). Using the lifetime data obtained in these
conditions, it was found that the onset of nystatin
oligomerization was much higher in ergosterol-containing
liposomes (ÆAæ*  100) compared to gel-phase DPPC
vesicles (ÆAæ*  10) (Fig. 3 A). Therefore, the phase/lipid
composition of the lipid vesicles must be controlling nystatin
ability to oligomerize through modulation of its aggregation
number and/or the degree of reversibility of this process. To
test this hypothesis, the cooperative partition model de-
veloped earlier for nystatin (Coutinho and Prieto, 2003) was
ﬁtted to the experimental data of Ætæ versus ÆAæ obtained in
the presence of a large excess of ergosterol (Fig. 3). Brieﬂy,
this model considers that monomeric nystatin molecules
partition into the lipid bilayer surface and reversibly
assemble into aggregates of z antibiotic molecules, with an
association constant, K#ag. Although our studies strongly
suggest that nystatin-ergosterol complexes are formed in the
lipid bilayer, where p molecules of membrane-bound
monomeric nystatin, N, and q molecules of ergosterol, E,
react to form a complex NpEq, the use of a nonlimiting
concentration of ergosterol ensures that the recovered
aggregation number, z, accurately describes nystatin stoi-
chiometry, p, in the mixed aggregates formed. In these
conditions K#ag is an apparent equilibrium constant and
therefore its value is no longer comparable with the one
obtained with gel-phase DPPC vesicles.
In the ﬁtting procedure, it was arbitrarily assumed that
the liposomes were POPC LUV containing 30 mol%
ergosterol. Therefore, the partition coefﬁcient of nystatin and
the average number of lipids in a single liposome were ﬁxed
to Kp ¼ 1.4 3 104 (Table 2) and m ¼ 120,847 (Table 1),
respectively. The amplitude- and intensity-weighted mean
lifetimes chosen for monomeric (tMl ¼ 1:0 ns and ÆtæMl ¼
3:3 ns; respectively, where t ¼ +n
i¼1 aiti

+n
i¼1 ai) and
aggregated nystatin (tAgl ¼ 6:5 ns and ÆtæAgl ¼ 38 ns; re-
spectively) were based upon the limiting values experimen-
tally found for very diluted and concentrated nystatin
samples in interaction with ergosterol-containing POPC
LUV (xErg $ 10 mol%). Due to the high cross correlation
between z and K#ag; z (integer) was ﬁxed and K#ag was varied
in each RMS minimization, where RMS is the root-mean-
square deviation between the experimental and calculated
values for the intensity-weighted mean ﬂuorescence lifetime
of nystatin, Ætæexp and Ætæcalc, respectively (Coutinho and
Prieto, 2003). Fig. 3 B shows that nystatin reversibly
assembled into aggregates of eight antibiotic molecules
with a two-standard-deviation conﬁdence interval of [6,12]
calculated using the support plane method (Straume et al.,
1991). The higher limit of z is rather ill-deﬁned due to the
pronounced asymmetry in the error curve (Fig. 3 B). This
aggregation number is not statistically signiﬁcantly larger
than the value obtained earlier for gel-phase DPPC SUV and
LUV (z ¼ 6 6 2) (Coutinho and Prieto, 2003).
The most surprising result of this study was the contrasting
effect that ergosterol and cholesterol had upon the photo-
physical behavior of nystatin, particularly the observation
that the mean lifetime of the antibiotic was essentially
independent of the mol fraction of cholesterol used in the
preparation of the lipid vesicles (Fig. 2 A). This result was
much unexpected because previous ﬂuorescence studies
carried out with trans-parinaric acid (t-PnA) had shown that
the ﬂuorescence emission decay kinetics of this tetraene-
containing ﬂuorescent fatty acid was very sensitive to the
cholesterol content of the liposomes (Mateo et al., 1995). The
opposite results obtained with nystatin and t-PnA may be
related to the preferential solubility of t-PnA in a liquid-
ordered phase (Mateo et al., 1995), which increases its ability
to detect the formation of a ‘o phase in POPC/cholesterol
binary mixtures. In conclusion, the main factor governing the
ﬂuorescence emission kinetics of nystatin seems to be its
oligomeric state and not the physical properties of the
hydrophobic core of the lipid bilayers, at variance with t-PnA.
Molecular mechanism of pore formation by
nystatin in ergosterol-containing POPC LUV
The data presented in Fig. 6 suggest that nystatin exerts its
antibiotic activity by permeabilizing the target ergosterol-
containing membrane via a two-stage mechanism. When the
mean number of membrane-bound antibiotic molecules was
low (ÆAæ # 100, stage I) nystatin induced a moderate
dissipation of the electrochemical gradient 300 s after the
beginning of each assay (Fig. 6 A). This process was further
characterized by a low apparent initial rate of pore formation
(Fig. 6 B). For ÆAæ $ 100 (stage II), this parameter sharply
increased (Fig. 6 B), leading to an almost instantaneous and
full dissipation of the transmembrane K1 gradient 300 s after
nystatin addition to the lipid vesicles (Fig. 6 A). Concom-
itantly, and only in ergosterol-containing membranes, there
was a rise in the mean ﬂuorescence lifetime of the antibiotic
(Fig. 6 C). The large value found for the critical
concentration of nystatin (ÆAæ*  100) could imply that
a complete loss of membrane barrier function might be
involved in the second stage of liposome permeabilization by
this antibiotic, as it was proposed earlier in the carpet model
described by Shai and co-workers for the antimicrobial
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peptides (Shai, 1999). However, this hypothesis was ruled
out because: i), control experiments showed that the light-
scattered intensity by the liposome population did not vary
during the activity assays, and ii), ,1% of the external
surface area of a 100-nm diameter large unilamellar vesicle is
occupied by 100 horizontally adsorbed nystatin molecules,
considering 1.8–1.9 nm2 per molecule (Seoane et al., 1997).
Another possibility is that for each stage of membrane
permeabilization, different antibiotic active species are
formed by nystatin in the lipid bilayer. For low vesicle
occupancy numbers (stage I), monomeric nystatin molecules
anchored at the lipid-water interface must predominate in the
lipid vesicles, as it was previously found for nystatin in
interaction with gel-phase DPPC vesicles (Coutinho and
Prieto, 2003). The antibiotic molecules embedded in the
headgroup region of the bilayer, presenting a short mean
ﬂuorescence lifetime, must transiently perturb its interfacial
structure, diminishing its selective permeability properties
toward the potassium ions. When the occupancy number of
the vesicles surpasses a critical value (stage II), which is
dependent upon the lipid composition of the liposomes, the
classical model of transmembrane pore formation by nystatin
must prevail. The antibiotic and ergosterol assemble in the
lipid bilayer, forming membrane-spanning channels perme-
able to ions, water, and nonelectrolytes. Therefore, a pore
encompasses a broad deﬁnition in this work, corresponding
to very different organizational levels of the antibiotic in the
membrane: it includes not only channel formation but also
any membrane structural defect induced by the polyene
antibiotic that facilitates the diffusion of ions across the lipid
bilayer. The key steps of this putative model are similar to
the sequential mechanism proposed earlier by Cohen and
co-workers to explain the effects exerted by AmB upon the
selective permeability properties of liposomes and plasma
membrane vesicles prepared from Leishmania sp. (Cohen,
1992). Brieﬂy, the authors considered that AmB could form
two different types of channels in sterol-containing lipo-
somes, whose appearance was dependent both on the
antibiotic concentration used and on the time elapsed since
its addition to the medium. For low antibiotic concentrations,
nonaqueous prepore structures (ionic channels) were formed
without the direct participation of sterol molecules. These
initially formed nonaqueous channels subsequently inter-
acted with the sterols in the membrane to form aqueous
channels, having an enlarged diameter. Several other
investigators have also shown that the polyene antibiotics
are able to form different types of channels in ergosterol- and
cholesterol-containing liposomes (Hartsel et al., 1994), as
well as in erythrocytes (Cybulska et al., 1995), which are
antibiotic-, concentration- and time-dependent.
An interesting point stems from the observation of Fig. 6,
A and C. Although the addition of 10 mM nystatin to 10
mol% ergosterol-containing lipid vesicles (ÆAæ ¼ 114)
already induces an almost instantaneous and full dissipation
of the transmembrane potassium gradient, the mean ﬂuo-
rescence lifetime of the antibiotic is far from reaching its
maximum value in these experimental conditions (Fig. 6 C).
This result can be explained by the different sensitivities of
the spectroscopic and functional assays to the extension of
aggregate formation by nystatin and ergosterol in the
liposomes. The formation of a single aggregate/channel in
a lipid vesicle is sufﬁcient to originate the full dissipation of
its transmembrane electrochemical gradient in the ‘‘all-or-
none’’ mode of antibiotic action. However, the mean
ﬂuorescence lifetime of nystatin approaches its limiting
value, ÆtæAgl , only when a large fraction of the monomeric
membrane-bound antibiotic molecules has undergone ag-
gregation in the lipid vesicles.
Molecular architecture of the pores formed
by nystatin
Nystatin showed a slow but signiﬁcant activity in sterol-free
POPC liposomes under iso-osmotic conditions within the
antibiotic concentration range studied (0–25 mM) (Fig. 6, A
and B) in agreement with the results obtained for AmB
(Ruckwardt et al., 1998). The inclusion of 10 mol%
cholesterol in the composition of the lipid vesicles
incremented the antibiotic activity (Fig. 6 A). Nevertheless,
although it was found that the antibiotic was able to almost
completely collapse the transmembrane potassium gradient
imposed on, e.g., 10 mol% cholesterol-containing POPC
LUV, as it did with 10 mol% ergosterol-containing POPC
LUV (Fig. 6 A), surprisingly there were no kinetic nor
spectroscopic/photophysical evidences for aggregate forma-
tion by nystatin in these conditions. According to the above
reasoning, these results seem to indicate that nystatin does
not reach the second phase of its mode of action in the
presence of sterol-free and 10 mol% cholesterol-containing
POPC LUV, e.g., because the antibiotic molecules remain
predominantly surface embedded in the liposomes in these
conditions.
Alternatively, nystatin may form different ion channels in
the membrane, which present distinct spectroscopic and
photophysical properties. In this study, it was shown that the
excitation and emission spectra of nystatin were strongly
antibiotic concentration dependent (Fig. 1, D and E)
reporting a structural rearrangement undergone by the
antibiotic molecules upon aggregate formation only within
the ergosterol-rich POPC membranes. In contrast, a similar
transition from a short- to a long-lived ﬂuorescent species
(i.e., from a monomeric to an oligomeric state of the
antibiotic) was not accompanied by any spectral alterations
in gel-phase DPPC vesicles (Coutinho and Prieto, 2003).
The changes detected here in nystatin ﬂuorescence spectra
are typical of excitonic interactions and have been reported
earlier for several polyene antibiotics (Castanho et al., 1992;
Gruszecki et al., 2003). The transition dipolar moments of
the chromophores must be close and parallel to each other in
the oligomers formed by the antibiotic because the excitonic
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splitting results in a higher intensity at lower wavelengths in
nystatin excitation spectra. Therefore, these data show
unequivocally that the packing of nystatin molecules in its
long-lived ﬂuorescent assemblies (like the spacing and
relative orientation between the polyene chains), is critically
inﬂuenced by the physical state (gel phase) and/or type of
sterol included in the membrane. This hypothesis is also
supported by the experimental study of Brutyan and McPhie
(1996), which has shown that the one-sided action of the
polyene antibiotic AmB on phospholipid bilayer membranes
formed from synthetic phosphatidylcholines (DOPC and
DPhPC) and sterols (ergosterol and cholesterol) produced
channels that had comparable conductances but very dif-
ferent lifetimes (;100-fold less in cholesterol-containing
membranes than in ergosterol-containing ones; see Fig. 4
in Brutyan and McPhie, 1996). Baginski et al. (2002) in their
molecular modeling study also indicated that AmB channels
in ergosterol-containing membranes are more stable than in
cholesterol-containing membranes. Other studies have also
shown that in addition to the sterol structure, other factors
like the ionic character of the molecules (Cybulska et al.,
1985; Herve´ et al., 1989) or the lipid composition of the
membrane (Matsuoka and Murata, 2003) can inﬂuence the
permeabilization mechanism of the lipid vesicles by polyene
antibiotics, which can switch from an ‘‘all-or-none’’ to
a graded or progressive type. It is therefore possible that
besides their stability, the spectroscopic and photophysical
properties of the putative supramolecular complexes formed
by the polyene antibiotics and sterols are also inﬂuenced by
their molecular architecture. In particular, the local ‘‘rigid-
ity’’ sensed by the chromophores in the channel may vary
with the sterol that putatively is involved in their formation.
If the channels formed by nystatin adopt a looser, less-com-
pact structure in cholesterol than in ergosterol-containing
membranes, as suggested by the steady-state ﬂuorescence
anisotropy measurements of the antibiotic (Fig. 4), nystatin
mean ﬂuorescence lifetime might not vary upon reaching
stage II of its putative mechanism of action, at variance
with what was found with ergosterol/POPC LUV.
CONCLUSIONS
This study demonstrates that nystatin is a membrane-active
compound that may present two distinct phases in its mode
of action. A nonspeciﬁc membrane permeabilization mech-
anism is proposed for low occupancy numbers of the
ergosterol-containing lipid vesicles, in which surface-
associated antibiotic molecules transiently induce structural
defects in the membrane, thereby perturbing its selective
permeability properties. These monomeric antibiotic mole-
cules characteristically present a low mean ﬂuorescence
lifetime of 5 ns and slowly dissipate the transmembrane
potassium gradient imposed on the lipid vesicles. When the
mean number of membrane-bound antibiotic molecules
surpasses a critical value of ÆAæ*  100, a transition to the
classical model of nystatin transmembrane aqueous channel
formation happens. Long-lived ﬂuorescent antibiotic species
(Ætæ  37 ns) are now formed, reporting nystatin oligomer-
ization in the lipid vesicles. These aggregates present a much
faster apparent initial rate of pore formation, which leads to
an almost full and instantaneous dissipation of the trans-
membrane K1 gradient present across the lipid vesicles.
Concomitantly, alterations in nystatin excitation spectra are
detected, which are typical of excitonic coupling. Both our
spectroscopic and functional data suggest that nystatin is not
able to reach the second stage of its mechanism of action
upon interacting with cholesterol-containing POPC LUV
because the ability to dissipate a potassium gradient was not
concurrent with any alteration in the spectral or photo-
physical properties of the antibiotic. Alternatively, the
molecular architecture of the aggregates formed by nystatin
in these experimental conditions may originate very unstable
assemblies, which do not rigidify sufﬁciently the polyene
chains to cause an increase in the antibiotic mean
ﬂuorescence lifetime.
This work was supported by a grant from Fundacxa˜o para a Cieˆncia e
Tecnologia (POCTI/FCB/36389/2000). L.S. and A.F. acknowledge
research grants BD/10029/2002 and BPD/11488/2002, respectively, from
Fundacxa˜o para a Cieˆncia e Tecnologia, Portugal.
REFERENCES
Albro, P. W., P. Bilski, J. T. Corbett, J. L. Schroeder, and C. F. Chignell.
1997. Photochemical reactions and phototoxicity of sterols: novel self-
perpetuating mechanism for lipid photooxidation. Photochem. Photobiol.
66:316–325.
Baginski, M., H. Resat, and E. Borowski. 2002. Comparative molecular
dynamics simulations of amphotericin B-cholesterol/ergosterol mem-
brane channels. Biochim. Biophys. Acta. 1567:63–78.
Bolard, J. 1986. How do the polyene macrolide antibiotics affect the
cellular membrane properties? Biochim. Biophys. Acta. 864:257–304.
Bolard, J., P. Legrand, F. Heitz, and B. Cybulska. 1991. One-sided action
of amphotericin B on cholesterol-containing membranes is determined
by its self-association in the medium. Biochemistry. 30:5707–5715.
Brutyan, R. A., and P. McPhie. 1996. On the one-sided action of
amphotericin B on lipid bilayer membranes. J. Gen. Physiol. 107:69–78.
Castanho, M. A. R. B., A. Coutinho, and M. J. E. Prieto. 1992. Absorption
and ﬂuorescence spectra of polyene antibiotics in the presence of
cholesterol. J. Biol. Chem. 267:204–209.
Cohen, B. E. 1992. A sequential mechanism for the formation of aqueous
channels by amphotericin B in liposomes. The effect of sterols and
phospholipid composition. Biochim. Biophys. Acta. 1108:49–58.
Coutinho, A., and M. Prieto. 1995. Self-association of the polyene
antibiotic nystatin in dipalmitoylphosphatidylcholine vesicles: a time-
resolved ﬂuorescence study. Biophys. J. 69:2541–2557.
Coutinho, A., and M. Prieto. 2003. Cooperative partition model of nystatin
interaction with phospholipid vesicles. Biophys. J. 84:3061–3078.
Cybulska, B., J. Bolard, O. Seksek, A. Czerwinski, and E. Borowski. 1995.
Identiﬁcation of the structural elements of amphotericin B and other
polyene macrolide antibiotics of the heptaene group inﬂuencing the ionic
selectivity of the permeability pathways formed in the red cell
membrane. Biochim. Biophys. Acta. 1240:167–178.
Cybulska, B., M. Herve´, E. Borowski, and C. M. Gary-Bobo. 1985. Effect
of the polar head structure of polyene macrolide antifungal antibiotics on
Sterols Inﬂuence Nystatin Self-Assembly 3275
Biophysical Journal 87(5) 3264–3276
the mode of permeabilization of ergosterol- and cholesterol-containing
lipidic vesicles studied by 31P-NMR. Mol. Pharmacol. 29:293–298.
de Almeida, R. F., A. Fedorov, and M. Prieto. 2003. Sphingomyelin/
phosphatidylcholine/cholesterol phase diagram: boundaries and compo-
sition of lipid rafts. Biophys. J. 85:2406–2416.
de Kruijff, B., and R. A. Demel. 1974. Polyene antibiotic-sterol interactions
in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3.
Molecular structure of the polyene antibiotic-cholesterol complexes.
Biochim. Biophys. Acta. 339:57–70.
Dufourc, E. J., and I. C. Smith. 1985. 2H NMR evidence for antibiotic-
induced cholesterol immobilization in biological model membranes.
Biochemistry. 24:2420–2424.
Dufourc, E. J., I. C. Smith, and H. C. Jarrel. 1984. Interaction of
amphotericin B with membrane lipids as viewed by 2H-NMR. Biochim.
Biophys. Acta. 778:435–442.
Endress, E., S. Bayerl, K. Prechtel, C. Maier, R. Merkel, and T. M. Bayerl.
2002. The effect of cholesterol, lanosterol, and ergosterol on lecithin
bilayer mechanical properties at molecular and microscopic dimensions:
a solid-state NMR and micropipet study. Langmuir. 18:3293–3299.
Ermishkin, L. N., K. M. Kasumov, and V. M. Potseluyev. 1977. Properties
of amphotericin B channels in a lipid bilayer. Biochim. Biophys. Acta.
470:357–367.
Gruszecki, W. I., M. Gagos, and M. Herec. 2003. Dimers of polyene
antibiotic amphotericin B detected by means of ﬂuorescence spectros-
copy: molecular organization in solution and in lipid membranes.
J. Photochem. Photobiol. B. 69:49–57.
Hartsel, S. C., S. K. Benz, W. Ayenew, and J. Bolard. 1994. Na1, K1 and
Cl selectivity of the permeability pathways induced through sterol-
containing membrane vesicles by amphotericin B and other polyene
antibiotics. Eur. Biophys. J. 23:125–132.
Hartsel, S. C., S. K. Benz, R. P. Peterson, and B. S. Whyte. 1991.
Potassium-selective amphotericin B channels are predominant in vesicles
regardless of sidedness. Biochemistry. 30:77–82.
Hartsel, S. C., C. Hatch, and W. Ayenew. 1993. How does amphotericin B
work? Studies on model membrane systems. J. Liposome Res. 3:377–408.
Herve´, M., J. C. Debouzy, E. Borowski, B. Cybulska, and C. M. Gary-
Bobo. 1989. The role of the carboxyl and amino groups of polyene
macrolides in their interactions with sterols and their selective toxicity. A
31P-NMR study. Biochim. Biophys. Acta. 980:261–272.
Kleinberg, M. E., and A. Finkelstein. 1984. Single-length and double-
length channels formed by nystatin in lipid bilayer membranes.
J. Membr. Biol. 80:257–269.
Kornberg, R. D., M. G. McNamee, and H. M. McConnell. 1972.
Measurement of transmembrane potentials in phospholipid vesicles.
Proc. Natl. Acad. Sci. USA. 69:1508–1513.
Lakowicz, J. R. 1999. Principles of Fluorescence Spectroscopy. Plenum
Press, New York, NY.
Mateo, C. R., A. U. Acuna, and J. C. Brochon. 1995. Liquid-crystalline
phases of cholesterol/lipid bilayers as revealed by the ﬂuorescence of
trans-parinaric acid. Biophys. J. 68:978–987.
Matsuoka, S., and M. Murata. 2003. Membrane permeabilizing activity of
amphotericin B is affected by chain length of phosphatidylcholine added
as minor constituent. Biochim. Biophys. Acta. 1617:109–115.
Mayer, L. D., M. J. Hope, and P. R. Cullis. 1986. Vesicles of variable sizes
produced by a rapid extrusion procedure. Biochim. Biophys. Acta.
858:161–168.
McClare, C. W. 1971. An accurate and convenient organic phosphorous
assay. Anal. Biochem. 39:527–530.
Milhaud, J., M. A. Hartmann, and J. Bolard. 1989. Interaction of the
polyene antibiotic amphotericin B with model membranes: differences
between small and large unilamellar vesicles. Biochimie. 71:49–56.
Nakashima, N., S. R. Meech, A. R. Auty, A. C. Jones, and D. Phillips.
1985. Fluorescence properties of ergosterol. J. Photochem. 30:
207–214.
Ruckwardt, T., A. Scott, J. Scott, P. Mikulecky, and S. C. Hartsel. 1998.
Lipid and stress dependence of amphotericin B ion selective channels in
sterol-free membranes. Biochim. Biophys. Acta. 1372:283–288.
Schwarz, G., and A. Arbuzova. 1995. Pore kinetics reﬂected in the
dequenching of a lipid vesicle entrapped ﬂuorescent dye. Biochim.
Biophys. Acta. 1239:51–57.
Schwarz, G., and C. H. Robert. 1990. Pore formation kinetics in membranes
determined from the release of marker molecules out of liposomes or
cells. Biophys. J. 58:577–583.
Schwarz, G., and C. H. Robert. 1992. Kinetics of pore-mediated release of
marker molecules from liposomes or cells. Biophys. Chem. 42:291–296.
Seoane, J. R., N. Vila Romeu, J. Min˜ones, O. Conde, P. Dynarowicz, and
M. Casas. 1997. The behavior of amphotericin B monolayers at the air/
water interface. Progr. Colloid Polym. Sci. 105:173–179.
Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of
phospholipid bilayer membranes by alpha-helical antimicrobial and cell
non-selective membrane-lytic peptides. Biochim. Biophys. Acta.
1462:55–70.
Smaby, J. M., M. M. Momsen, H. L. Brockman, and R. E. Brown. 1997.
Phosphatidylcholine acyl unsaturation modulates the decrease in in-
terfacial elasticity induced by cholesterol. Biophys. J. 73:1492–1495.
Straume, M., S. G. Frasier-Cadoret, and M. L. Johnson. 1991. Least-
squares analysis of ﬂuorescence data. In Topics in Fluorescence
Spectroscopy: Principles, Vol. 2. J. R. Lakowicz, editor. Plenum Press,
New York, NY. 177–240.
Straume, M., and B. J. Litman. 1987. Inﬂuence of cholesterol on
equilibrium and dynamic bilayer structure of unsaturated acyl chain
phosphatidylcholine vesicles as determined from higher order analysis of
ﬂuorescence anisotropy decay. Biochemistry. 26:5121–5126.
Urbina, J. A., S. Pekerar, H. B. Le, J. Patterson, B. Montez, and E. Oldﬁeld.
1995. Molecular order and dynamics of phosphatidylcholine bilayer
membranes in the presence of cholesterol, ergosterol and lanosterol:
a comparative study using 2H-, 13C- and 31P-NMR spectroscopy.
Biochim. Biophys. Acta. 1238:163–176.
Vist, M. R., and J. H. Davis. 1990. Phase equilibria of cholesterol/
dipalmitoylphosphatidylcholine mixtures: 2H nuclear magnetic reso-
nance and differential scanning calorimetry. Biochemistry. 29:451–464.
Weakliem, C. L., G. Fujii, J.-E. Chang, A. Ben-Shaul, and W. M. Gelbart.
1995. Effect of tension on pore formation in drug-containing vesicles.
J. Phys. Chem. 99:7694–7697.
White, S. H., W. C. Wimley, A. S. Ladokhin, and K. Hristiva. 1998. Protein
folding in membranes: determining energetics of peptide-bilayer
interactions. Methods Enzymol. 295:62–87.
Whyte, B. S., R. P. Peterson, and S. C. Hartsel. 1989. Amphotericin B and
nystatin show different activities on sterol-free vesicles. Biochem.
Biophys. Res. Commun. 164:609–614.
3276 Coutinho et al.
Biophysical Journal 87(5) 3264–3276
